Medtronic has received the CE Mark for its Export Advance aspiration catheter and is planning to launch the product in Europe and other international markets.
The new thrombus removal system is built with full-wall variable braiding technology that offers stiffness to the device to improve flexibility and pushability for optimal catheter performance.
Hamilton Health Sciences interventional cardiologist Sanjit Jolly said that when thrombus completely or partially blocks an artery, aspiration is an important first step of the treatment process that can improve clinical outcomes.
"Removing thrombus with highly effective aspiration catheters, such as those in the Export family, is especially critical when faced with a patient having a heart attack in order to access the lesion quickly and restore blood flow as soon as possible," Jolly added.
The Export Advance aspiration catheter features a pre-loaded stylet, which increases the deliverability and kink resistance of the device when traversing the anatomy to reach the aspiration site.
Medtronic coronary business vice president and general manager Jason Weidman said that with more than ten years of market leadership in this product category, Medtronic has continued to lead the way in innovation, setting a new standard of performance with the Export Advance aspiration catheter.
"In addition to superior deliverability, our next-generation device offers high-performing aspiration power that physicians have come to expect from Export aspiration catheters, which to date have been used to treat more than one million patients worldwide," Weidman added.
The Export Advance aspiration catheter is not approved for use in the US.
Image: The world headquarters of Medtronic. Photo: Courtesy of Bobak Ha’Eri.